ADVFN Logo ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
サインイン Premium Iconプレミアム Help Menu
Bitcoin
68,195.44
-1.73%
S&P 500
5,293.42
-0.21%
Dow Jones
38,762.04
-0.79%
US Dollar vs Yen
157.1305
0.18%
Brent Oil
84.275
1.73%
Registration Strip Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
登録
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. NASDAQ
  6. Iovance Biotherapeutics Inc (IOVA)

  7. Iovance Biotherapeutics Inc (IOVA) ニュース

IOVA

Iovance Biotherapeutics (IOVA)

Iovance Biotherapeutics Inc
から:
次の項目別のソート:
 Showing the most relevant articles for your search:NASDAQ:IOVA
日付受信時刻ニュースソース見出しコード企業名
2024/05/2505 : 01GlobeNewswire Inc.Iovance Biotherapeutics to Present at Upcoming Conferences and EventsNASDAQ:IOVAIovance Biotherapeutics Inc
2024/05/2406 : 00GlobeNewswire Inc.Iovance Biotherapeutics Announces Clinical Data in Frontline Advanced Melanoma at ASCO 2024 Annual MeetingNASDAQ:IOVAIovance Biotherapeutics Inc
2024/05/1806 : 15Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:IOVAIovance Biotherapeutics Inc
2024/05/1806 : 15GlobeNewswire Inc.Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)NASDAQ:IOVAIovance Biotherapeutics Inc
2024/05/1006 : 10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IOVAIovance Biotherapeutics Inc
2024/05/1006 : 10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:IOVAIovance Biotherapeutics Inc
2024/05/1005 : 06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IOVAIovance Biotherapeutics Inc
2024/05/1005 : 01GlobeNewswire Inc.Iovance Biotherapeutics Reports First Quarter 2024 Financial Results and Corporate UpdatesNASDAQ:IOVAIovance Biotherapeutics Inc
2024/05/0119 : 01GlobeNewswire Inc.Iovance Biotherapeutics to Host First Quarter 2024 Financial Results Conference Call and Webcast on Thursday, May 9, 2024NASDAQ:IOVAIovance Biotherapeutics Inc
2024/04/3019 : 01GlobeNewswire Inc.Iovance Biotherapeutics to Present at Upcoming ConferencesNASDAQ:IOVAIovance Biotherapeutics Inc
2024/04/2505 : 01GlobeNewswire Inc.Iovance Biotherapeutics to Present Clinical and Translational Data at 2024 ASCO Annual MeetingNASDAQ:IOVAIovance Biotherapeutics Inc
2024/04/2006 : 15GlobeNewswire Inc.Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)NASDAQ:IOVAIovance Biotherapeutics Inc
2024/03/2306 : 30GlobeNewswire Inc.Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)NASDAQ:IOVAIovance Biotherapeutics Inc
2024/03/0708 : 17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IOVAIovance Biotherapeutics Inc
2024/03/0607 : 56Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IOVAIovance Biotherapeutics Inc
2024/03/0607 : 53Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IOVAIovance Biotherapeutics Inc
2024/03/0607 : 52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IOVAIovance Biotherapeutics Inc
2024/03/0607 : 52Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IOVAIovance Biotherapeutics Inc
2024/03/0607 : 51Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IOVAIovance Biotherapeutics Inc
2024/03/0607 : 50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:IOVAIovance Biotherapeutics Inc
2024/03/0422 : 00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IOVAIovance Biotherapeutics Inc
2024/03/0420 : 30GlobeNewswire Inc.Iovance Biotherapeutics Announces FDA has Lifted Clinical Hold on the IOV-LUN-202 Registrational Trial in Non-Small Cell Lung CancerNASDAQ:IOVAIovance Biotherapeutics Inc
2024/03/0207 : 00GlobeNewswire Inc.Iovance Biotherapeutics to Present at Upcoming ConferencesNASDAQ:IOVAIovance Biotherapeutics Inc
2024/02/2921 : 30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IOVAIovance Biotherapeutics Inc
2024/02/2906 : 05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IOVAIovance Biotherapeutics Inc
2024/02/2906 : 01GlobeNewswire Inc.Iovance Biotherapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Updates NASDAQ:IOVAIovance Biotherapeutics Inc
2024/02/2306 : 53Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IOVAIovance Biotherapeutics Inc
2024/02/2222 : 45GlobeNewswire Inc.Iovance Biotherapeutics to Host Fourth Quarter and Full-Year 2023 Financial Results Conference Call and Webcast on Wednesday, February 28, 2024NASDAQ:IOVAIovance Biotherapeutics Inc
2024/02/2206 : 44Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:IOVAIovance Biotherapeutics Inc
2024/02/2107 : 23Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:IOVAIovance Biotherapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:IOVA

最近閲覧した銘柄

USOTC
BASFY
BASF (QX)
CCOM
SILVER
SILVER
AMEX
XLV
Health Care Select Sector
NASDAQ
NVDA
NVIDIA
AMEX
XLE
Energy Select Sector SPDR
NYSE
BAC
Bank of America
NASDAQ
AMZN
Amazon.com
NYSE
MRK
Merck
CCOM
US500
US 500
USOTC
BNPQY
BNP Paribas (QX)
NASDAQ
QQQ
Invesco QQQ Trust Series 1
USOTC
RHHBY
Roche (QX)
NYSE
NKE
Nike
FX
USDEUR
US Dollar vs Euro
CCOM
US100
US Tech 100
NASDAQ
GOOGL
Alphabet
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2024 ADVFN PLC - 全著作権所有